Study guide

8.3 Antepartum Haemorrhage: Placenta Praevia, Placental Abruption & Vasa Praevia

NMC Test of Competence Part 1: Midwifery Computer-Based Test Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: NMC Framework, Autonomy & Professional Ethics

1.1 NMC Regulatory Architecture, RM Registration & The Code 1.2 Autonomous Midwifery Practice, Accountability & Delegation 1.3 Informed Consent, Capacity, Advocacy & Human Rights 1.4 Duty of Candour, Confidentiality & Clinical Documentation Human Rights, Equality, Anti-Discriminatory & Culturally Sensitive Care

2 Chapter 2: Continuity, Public Health & Perinatal Mental Health

2.1 Continuity of Carer & Physiological Midwifery Care 2.2 Public Health, Social Determinants & Health Inequalities 2.3 Perinatal Mental Health Assessment & Emergency Psychiatric Care UK Health & Social Care System, Birth Settings, Safe Staffing & Keeping Mothers and Babies Together

3 Chapter 3: Safeguarding, Vulnerable Populations & FGM

3.1 Safeguarding Children & Adults at Risk in Maternity Care 3.2 Domestic Abuse Identification, Risk Assessment & Multi-Agency Referral 3.3 FGM Mandatory Reporting, Clinical Classification & Trauma-Informed Practice

4 Chapter 4: Universal Antenatal Care & Fetal Assessment

4.1 Antenatal Care Schedule, Physiological Adaptations & Routine Investigations 4.2 Fetal Growth Surveillance, Fundal Height & Symphysis-Fundal Height (SFH) Plotting 4.3 UK National Screening Committee (UK NSC) Antenatal Screening Programmes 4.4 Antenatal Education, Birth Planning & Minor Disorders of Pregnancy Reproductive Anatomy, Genetics & Genomics, Embryology and Fetal Development

5 Chapter 5: Universal Intrapartum Care & Physiological Labour

5.1 Physiology of Normal Labour, Hormonal Regulation & Latent vs Active First Stage 5.2 Second Stage Management, Mechanisms of Normal Labour & Perineal Protection 5.3 Third Stage Management: Active vs Physiological & Examination of Placenta/Membranes 5.4 Pain Management in Labour: Non-Pharmacological & Pharmacological Analgesia

6 Chapter 6: Universal Postnatal Care & Infant Feeding

6.1 Physiological Maternal Postnatal Involution, Assessment & Recovery 6.2 Perineal Trauma Assessment, Classification (1st to 4th Degree) & Care Principles 6.3 Physiology of Lactation, Breastfeeding Support & UNICEF Baby Friendly Standards 6.4 Formula Feeding Safety, Responsive Bottle Feeding & Infant Growth Patterns Contraception & Sexual and Reproductive Health after Birth

7 Chapter 7: Newborn Assessment & Neonatal Care

7.1 Newborn Transition, Apgar Scoring, Thermoregulation & Skin-to-Skin Care 7.2 Newborn Physical Examination (NIPE 4 Core Elements) & Routine Prophylaxis 7.3 Neonatal Blood Spot Screening, Hearing Screening & Infection Prevention

8 Chapter 8: Medical & Obstetric Antenatal Complications

8.1 Pre-existing Medical Conditions in Pregnancy (Diabetes, Cardiac, Epilepsy, Renal) 8.2 Hypertensive Disorders of Pregnancy, Pre-eclampsia & Eclampsia 8.3 Antepartum Haemorrhage: Placenta Praevia, Placental Abruption & Vasa Praevia 8.4 Gestational Diabetes Mellitus (GDM): Screening, Diagnostic Criteria & Management

9 Chapter 9: Intrapartum Complications & Obstetric Emergencies

9.1 Postpartum Haemorrhage (PPH): Definition, 4Ts, Bimanual Compression & Medical Protocols 9.2 Shoulder Dystocia: Recognition, Risk Factors & HELPERR Emergency Sequence 9.3 Umbilical Cord Prolapse, Uterine Rupture & Amniotic Fluid Embolism 9.4 Maternal Sepsis, MEOWS Escalation & Maternal Resuscitation (Modified BLS/ALS)

10 Chapter 10: Fetal Compromise & Neonatal Complications

10.1 Intrapartum Fetal Heart Rate Monitoring & CTG Interpretation (NICE / FIGO) 10.2 Neonatal Resuscitation: Resuscitation Council UK NLS Algorithm 10.3 Neonatal Hypoglycaemia, Hyperbilirubinaemia & Neonatal Sepsis (NICE NG195) 10.4 Perinatal Loss, Bereavement Care & Perinatal Palliative Support

11 Chapter 11: Midwifery Pharmacology, Prescribing & Skills

11.1 Midwives Exemptions under Human Medicines Regulations 2012 & PGDs 11.2 Core Midwifery Medicines Administration & Controlled Drugs Storage/Recording 11.3 Episiotomy: Clinical Indications, Infiltration Technique & Incision Anatomy 11.4 Aseptic Non-Touch Technique (ANTT), Bladder Catheterisation & Cannulation Infection Prevention & Control, Communicable Disease Surveillance and Antimicrobial Stewardship

12 Chapter 12: Leadership, Multidisciplinary Safety & Quality

12.1 Interprofessional Team Communication, SBAR Handover & Human Factors 12.2 Incident Reporting, Root Cause Analysis & Learning from Reviews (MNSI, MBRRACE) 12.3 Midwife as Scholar, Clinical Supervisor, Leader & Escalating Safety Concerns Research Methods, Critical Appraisal, Audit & Service Evaluation Quality Improvement, Change Management, Sustainable Healthcare & Digital Practice Resilience, Wellbeing, Reflection, Human Factors & Leading Care

13 Chapter 13: Part A Numeracy & Drug Calculation Mastery

13.1 Metric Units, Conversions, Rounding & CBT Pearson VUE Numeric Answer Rules 13.2 Oral Medications, Liquid Suspensions & Solid Dose Calculations 13.3 Injectable Medicines, Dilutions, Percentages & Weight-Based Calculations 13.4 Intravenous Infusions, Flow Rates, Syntocinon/Oxytocin & Magnesium Sulfate Protocols

8.3 Antepartum Haemorrhage: Placenta Praevia, Placental Abruption & Vasa Praevia

Key Takeaways Explain This Topic AI

Antepartum haemorrhage (APH) is genital tract bleeding occurring from 24+0 weeks' gestation until birth, classified clinically as spotting, minor (<50 mL), major (50-1000 mL), or massive (>1000 mL or shock).

Placenta praevia presents with painless, bright red vaginal bleeding and a soft, non-tender uterus; digital vaginal examination is strictly contraindicated until ultrasound has definitively excluded praevia.

Placental abruption presents with severe, constant abdominal pain, dark vaginal bleeding (often concealed), a rigid 'woody' hard uterus, and fetal compromise, carrying severe risks of disseminated intravascular coagulation (DIC).

Vasa praevia involves unprotected fetal vessels traversing the membranes over the internal cervical os; rupture of membranes precipitates rapid fetal exsanguination with catastrophic bradycardia, demanding immediate category 1 caesarean section.

Major or massive APH requires immediate 2222 obstetric emergency activation, high-flow oxygen, two 14/16G IV cannulae, blood crossmatching (4-6 units), continuous CTG, and Kleihauer-Betke testing in RhD-negative women.

Last updated: October 2026

Antepartum Haemorrhage: Placenta Praevia, Placental Abruption & Vasa Praevia

Antepartum haemorrhage (APH) is defined as bleeding from or into the genital tract occurring from 24+0 weeks' gestation until the birth of the baby . APH complicates 3% to 5% of all pregnancies and represents a critical obstetric emergency associated with significant maternal morbidity, preterm birth, fetal hypoxia, and perinatal death. Clinical care in the UK is governed by the Royal College of Obstetricians and Gynaecologists (RCOG) Green-top Guideline No. 63 ( Antepartum Haemorrhage ) .

Definition & Severity Classification of Antepartum Haemorrhage

Bleeding before 24+0 weeks is classified as threatened or inevitable miscarriage. From 24+0 weeks onwards, APH is stratified into four clinical severity tiers based on estimated blood loss and hemodynamic impact:

Severity Tier Estimated Blood Loss Volume Clinical Features & Hemodynamic Presentation

Spotting Staining, streaking, or blood spots Minimal blood on underwear or sanitary towel; no hemodynamic compromise.

Minor Haemorrhage <50 mL Small volume loss that has settled; maternal vital signs completely stable.

Major Haemorrhage 50–1000 mL Substantial blood loss without clinical signs of maternal shock.

Massive Haemorrhage >1000 mL or signs of shock Extensive blood loss AND/OR clinical evidence of hemodynamic shock (tachycardia >100 bpm, hypotension, cold peripheries, pallor, oliguria, confusion).

Important

Clinical estimation of external vaginal blood loss consistently underestimates true haemorrhage. In conditions such as placental abruption, massive haemorrhage can remain entirely concealed behind the placenta, causing profound maternal hypovolaemic shock and fetal demise without visible external blood loss.

Placenta Praevia & Low-Lying Placenta

Placenta praevia occurs when the placenta implants entirely or partially in the lower uterine segment. Under RCOG terminology (Green-top Guideline No. 27):

Low-Lying Placenta : The lower placental edge lies within 20 mm (2.0 cm) of the internal cervical os on transvaginal ultrasound (TVS) in the third trimester, but does not cover it.

Placenta Praevia : The placenta directly covers the internal cervical os.

1. Risk Factors & Placenta Accreta Spectrum

Primary predisposing factors include: previous caesarean birth (risk multiplies with each subsequent caesarean hysterotomy scar), advanced maternal age (≥35 years), multiparity, assisted reproductive technology (IVF), multiple pregnancy, maternal smoking, and previous uterine curettage.

When a placenta praevia implants over a previous anterior caesarean scar, the risk of placenta accreta spectrum (PAS) —where chorionic villi abnormally adhere to or invade through the myometrium—rises steeply with each previous caesarean (with praevia, about 40% after three previous caesareans and more than 60% after four or more), creating catastrophic intrapartum haemorrhage risks.

2. Clinical Presentation

Haemorrhage : Painless, recurrent, bright red vaginal bleeding, often unprovoked and appearing spontaneously during rest or sleep.

Abdominal Palpation : The uterus is soft, relaxed, and non-tender .

Fetal Assessment : Fetal heart rate is usually normal and reassuring (unless maternal exsanguination causes terminal hypoperfusion).

Lie and Presentation : The presenting part is characteristically high, floating, and unengaged , or there is an abnormal fetal lie (transverse lie, oblique lie, or breech presentation) because the low placental mass mechanically obstructs fetal engagement in the pelvic brim.

3. The Strict Contraindication to Digital Vaginal Examination

Warning

NEVER PERFORM A DIGITAL VAGINAL EXAMINATION (PV) in any pregnant woman presenting with antepartum haemorrhage until placental localisation has been confirmed by ultrasound! Inserting examining fingers through the cervix can detach placental cotyledons from the vascular lower uterine segment, triggering catastrophic, uncontainable arterial haemorrhage that can prove fatal within minutes.

4. Antenatal Management & Timing of Birth

Asymptomatic women with confirmed placenta praevia are scheduled for elective caesarean delivery between 36+0 and 37+0 weeks' gestation (with antenatal corticosteroids administered prior to delivery). Women with low-lying placenta (10–20 mm from os) can be counselled regarding trial of vaginal birth if the fetal head is engaged and no bleeding occurs, though senior obstetrician involvement is required.

Placental Abruption (Abruptio Placentae)

Placental abruption is defined as the premature separation of a normally situated placenta from the uterine decidua basalis prior to the birth of the baby.

1. Pathophysiology & Revealed vs. Concealed Haemorrhage

Rupture of maternal decidual spiral arterioles leads to bleeding into the decidua basalis. The expanding retroplacental haematoma cleaves the placental attachment from the uterine wall, shearing overlying villous capillaries and destroying maternal-fetal gas exchange.

Revealed Haemorrhage (80% of cases) : Blood dissects between the fetal membranes and uterine decidua, escaping through the cervix into the vagina. The blood is typically dark red or brown.

Concealed Haemorrhage (20% of cases) : The margins of the placenta remain adherent, or the fetal head tightly occludes the lower uterine segment, trapping the entire haematoma behind the placenta. Maternal shock and coagulopathy develop rapidly despite minimal or absent visible vaginal loss.

2. Etiology & Risk Factors

Key triggers include: maternal pre-eclampsia and chronic hypertension (accounting for >50% of severe abruptions), previous placental abruption (10-fold increased recurrence), abdominal trauma (domestic abuse, road traffic collisions), sudden uterine decompression (rapid release of polyhydramnios fluid or birth of a first twin), maternal cocaine or amphetamine misuse, smoking, and advanced parity.

3. Clinical Presentation

Pain : Severe, continuous, agonizing abdominal or back pain with no pain-free interval.

Uterine Examination : The uterus is characteristically described as "woody" hard , intensely hypertonic, and tender on palpation. Uterine contractions are frequent and low-amplitude, with elevated resting tone.

Fetal Compromise : Severe fetal heart rate abnormalities: persistent baseline tachycardia, prolonged or late decelerations, loss of variability, sinusoidal pattern, or intrauterine fetal demise.

Maternal Shock : Tachycardia, hypotension, and pallor out of proportion to visible blood loss.

Disseminated Intravascular Coagulation (DIC) : Massive retroplacental tissue destruction releases huge amounts of tissue thromboplastin into maternal circulation, activating systemic coagulation cascades. Clotting factors and platelets are consumed rapidly, resulting in severe hypofibrinogenaemia (<2.0 g/L) and intractable microvascular haemorrhage.

Vasa Praevia

Vasa praevia is an uncommon but catastrophic obstetric condition wherein unprotected fetal blood vessels traverse the fetal membranes across the internal cervical os, positioned below the fetal presenting part without the protection of the umbilical cord or Wharton's jelly.

1. Pathogenesis & Anatomy

Vasa praevia arises in two primary configurations: velamentous cord insertion (where umbilical vessels insert into membranes away from the placental disc) or succenturiate placental lobes (where connecting intercotyledonary vessels bridge two lobes across the os).

2. The Clinical Triad of Rupture

Vasa praevia remains asymptomatic until the fetal membranes rupture spontaneously or artificially ( SROM or ARM ). When the membranes tear, the traversing fetal vessels are lacerated, resulting in:

Painless Vaginal Bleeding : Moderate, fresh vaginal bleeding occurring immediately at the moment of membrane rupture.

Catastrophic Fetal Deterioration : Sudden, severe fetal bradycardia, prolonged variable decelerations, or a classical sinusoidal fetal heart rate pattern on cardiotocography.

Normal Maternal Observations : Maternal vital signs, pulse, and blood pressure remain completely stable and unaffected, because the bleeding is entirely fetal .

Warning

At term, total fetoplacental blood volume is only 250 to 300 mL (80–90 mL/kg). A blood loss of merely 50 to 100 mL represents acute hypovolaemic shock and rapid exsanguination for the fetus. Vasa praevia diagnosed intrapartum requires an immediate Category 1 emergency caesarean section (delivery within 15–30 minutes) and immediate preparation for neonatal blood transfusion.

Comparison of Placenta Praevia, Abruption & Vasa Praevia

Clinical Parameter Placenta Praevia Placental Abruption Vasa Praevia

Nature of Bleeding Painless, recurrent, bright red Painful, constant, dark red (or concealed) Painless, fresh bleeding immediately following membrane rupture

Uterine Tone & Palpation Soft, relaxed, non-tender "Woody" hard , hypertonic, intensely tender Soft, normal resting tone between contractions

Fetal Heart Pattern Generally normal / reassuring Fetal distress, decelerations, or absent Sudden severe bradycardia or sinusoidal FHR

Maternal Hemodynamics Proportional to visible loss Disproportionate shock (concealed loss) Completely normal (bleeding is fetal)

Coagulopathy (DIC) Rare (only after massive shock) Common (thromboplastin release) Absent

Digital Examination Strictly contraindicated Contraindicated until ultrasound excludes praevia Contraindicated until ultrasound excludes praevia

Immediate Clinical Management of Major/Massive APH

When a pregnant woman presents with major or massive APH, the midwife must coordinate an immediate multidisciplinary emergency response:

Emergency Call (2222) : Summon the obstetric emergency team: senior obstetrician, senior midwife, obstetric anaesthetist, haematologist, and neonatal resuscitation team.

Resuscitation & Positioning : Position in left lateral tilt (15–30 degrees) to relieve aortocaval compression. Administer high-flow oxygen (15 L/min via non-rebreather mask) .

Intravenous Access : Secure two large-bore intravenous cannulae (14-gauge orange or 16-gauge grey) in the antecubital fossae.

Laboratory Blood Investigations :

Full Blood Count (FBC) : Evaluate baseline haemoglobin, haematocrit, and platelets.

Coagulation Profile : Prothrombin time (PT), activated partial thromboplastin time (APTT), and Fibrinogen (fibrinogen <2.0 g/L signals severe consumptive coagulopathy).

Renal & Liver Function : Urea, creatinine, electrolytes, and transaminases.

Group and Crossmatch : Crossmatch 4 to 6 units of packed red blood cells immediately. If un-crossmatched blood is needed for imminent arrest, request O-negative red cells .

Kleihauer-Betke Test : Mandatory in all Rhesus D-negative women to quantify the volume of feto-maternal haemorrhage (FMH) and calculate the dose of Anti-D immunoglobulin required above standard routine prophylaxis (standard 500 IU covers up to 4 mL FMH; 125 IU per additional 1 mL fetal red cells).

Fluid Resuscitation : Infuse up to 2,000 mL warmed crystalloids (Plasma-Lyte or 0.9% normal saline) while awaiting blood products. If bleeding is massive, activate the Massive Obstetric Haemorrhage Protocol (MOHP) to deliver red cells and, following the local protocol, fresh frozen plasma, platelets and fibrinogen replacement (cryoprecipitate or fibrinogen concentrate), guided by laboratory or point-of-care coagulation testing.

Fetal Monitoring : Continuous electronic fetal monitoring (CTG) if gestational age ≥24 weeks and fetus alive.

Expedited Delivery : Category 1 emergency caesarean birth is indicated for ongoing major/massive haemorrhage, maternal instability, placental abruption with fetal compromise, or vasa praevia.

Loading diagram... Differential Diagnosis and Emergency Response Algorithm for Antepartum Haemorrhage